Teladoc Health Inc (TDOC) Stock Price Today
Aura AI Summary
Key Stats
- $1.14BMarket Cap
- -Volume
- HealthSector
- $9.7252W High
- $4.4752W Low
- -Typical Hold Time
- $1.40BEnterprise Value
- -Div Yield
- -Trading Activity
Track Teladoc Health Inc (TDOC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Teladoc Health Inc has traded between a low of $4.47 and a high of $9.72, highlighting its annual price range. Buy and sell Teladoc Health Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Most Recent News
Ithaca Energy to join FTSE 100 on Sept 21, boosting investor exposure after key acquisitions.
Ithaca Energy PLC will be added to the FTSE 100 index on September 21, 2026, following FTSE Russell's latest review. This inclusion marks a significant milestone for the North Sea oil producer after expanding through acquisitions, including its merge...
Hutchmed shares jump 17% after $1.3B GSK deal for cancer drug rights outside China
Hutchmed's shares rose 17% after signing a licensing deal with GSK worth up to $1.295 billion for its experimental cancer drug HMPL-A830. GSK gains exclusive rights outside Mainland China, Hong Kong, Macau, and Taiwan, paying $110 million upfront plu...
Jones Lang LaSalle reports strong Q2 2026 growth with 11% revenue rise and 59% EPS increase
Jones Lang LaSalle (JLL), a global commercial real estate services firm, reported strong Q2 2026 results with an 11% increase in revenue, a 32% rise in adjusted EBITDA, and a 59% jump in adjusted EPS. The company benefits from stable income through r...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.